Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Linagliptin on Endothelial Function and Global Arginine Bioavailability Ratio in Coronary Artery Disease Patients With Early Diabetes

NCT02350478 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT02350478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02350478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Linagliptin on Endothelial Function and Global Arginine Bioavailability Ratio in Coronary Artery Disease Patients With Early Diabetes
Lead sponsor
Medical University of Graz
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
March 31, 2017
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, type 2 diabetes